ARGOS
Live / Registered — Registered and renewed (as of 20 Oct 2016)
What this means for you
Registered since 22 Aug 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal was due 22 Aug 2026; it can still be filed, with a surcharge, until 22 Feb 2027).
Record
- Serial number
- 78425166
- Registration number
- 3133913
- Mark type
- Word mark
- Filed
- 26 May 2004
- Published for opposition
- 13 Sept 2005
- Registered
- 22 Aug 2006
- Current term from
- 22 Aug 2016
- Next maintenance filing
- §8 & §9 renewal, due by 22 Aug 2026 (grace period to 22 Feb 2027)
- Attorney of record
- Holly A Coldiron
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and biologics for the treatment of cancer, infectious diseases, transplantation and autoimmune diseases
Owner
- ARGOS THERAPEUTICS, INC., DURHAM, NC, US
- ARGOS THERAPEUTICS, INC., DURHAM, NC, US
- ARGOS THERAPEUTICS, INC., DURHAM, NC, US
- MERIX Bioscience, Inc., Durham, NC, US
Prosecution history
- 22 Aug 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 Oct 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 20 Oct 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 20 Oct 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Oct 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Aug 2016 — TEAS SECTION 8 & 9 RECEIVED
- 22 Aug 2015 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 May 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Aug 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Aug 2012 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Aug 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Aug 2012 — TEAS SECTION 8 & 15 RECEIVED
- 22 Aug 2006 — REGISTERED-PRINCIPAL REGISTER
- 05 Jul 2006 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 23 Jun 2006 — ASSIGNED TO LIE